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Abstract
Cited2 is a transcriptional modulator with pivotal roles in different biological processes. Cited2-
deficient mouse embryos manifested two major defects in the developing eye. An abnormal corneal-
lenticular stalk was characteristic of Cited2−/− developing eyes, a feature reminiscent of Peters’
anomaly, which can be rescued by increased Pax6 gene dosage in Cited2−/− embryonic eyes. In
addition, the hyaloid vascular system showed hyaloid hypercellularity consisting of aberrant
vasculature, which might be correlated with increased VEGF expression in the lens. Deletion of
Hif1a (which encodes HIF-1α) in Cited2−/− lens specifically eliminated the excessive accumulation
of cellular mass and aberrant vasculature in the developing vitreous without affecting the corneal-
lenticular stalk phenotype. These in vivo data demonstrate for the first time dual functions for Cited2:
one upstream of, or together with, Pax6 in lens morphogenesis; and another in the normal formation
of the hyaloid vasculature through its negative modulation of HIF-1 signaling. Taken together, our
study provides novel mechanistic revelation for lens morphogenesis and hyaloid vasculature
formation and hence might offer new insights into the etiology of Peters’ anomaly and ocular
hypervascularity.
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INTRODUCTION
Cited2 [Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2]
is one of the founding members of a family of transcriptional modulators (Shioda et al.,
1997; Sun et al., 1998; Dunwoodie et al., 1998; Leung et al., 1999). Cited2 was previously
named melanocyte-specific gene (MSG) related gene 1 (Mrg1; p35srj) (Shioda et al., 1997;
Dunwoodie et al., 1998; Sun et al., 1998; Bhattacharya et al., 1999). It binds directly with high
affinity to the first cysteine-histidine-rich (CH1) region of the transcription co-factors p300
and CBP. As a CBP/p300-dependent transcription factor, Cited2 functions as a negative
regulator of hypoxia inducible factor 1 (HIF-1)-mediated signaling by competing with
HIF-1α for binding to CBP/p300 (Bhattacharya et al., 1999). Cited2 physically interacts with
several nuclear receptors and transcription factors, including PPAR (Ppara – Mouse Genome
Informatics) (Tien et al., 2004), Hnf4α (Qu et al., 2007), Lhx2 (Glenn and Maurer, 1999), AP2
(Tcfap2) transcription factors (Bamforth et al., 2001) and Smad2/3 (Chou et al., 2006). Cited2
is also induced by many biological stimuli such as cytokines, serum and lipopolysaccharide in
different cell types (Sun et al., 1998). Overexpression of Cited2 in Rat1 cells results in loss of
cell contact inhibition, anchorage-independent growth and tumor formation in nude mice,
demonstrating that Cited2 is a transforming gene (Sun et al., 1998). These initial in vitro studies
underscore the potential roles of Cited2 in different biological processes.
Deletion of Cited2 results in embryonic lethality in mid- to late gestation, with embryos
displaying cardiac malformations, neural tube defects, adrenal agenesis (Barbera et al., 2002;
Bamforth et al., 2001; Yin et al., 2002; Val et al., 2007), left-right patterning defects (Weninger
et al., 2005; Bamforth et al., 2004), placental defects (Withington et al., 2006), liver
developmental defects (Qu et al., 2007) and defective fetal hematopoiesis (Chen et al., 2007).
Further mechanistic studies have provided evidence that Cited2 plays pivotal roles in these
processes through its transcriptional modulator functions for HIF-1 (Yin et al., 2002; Xu et al.,
2007), AP2α (Tcfap2α – Mouse Genome Informatics) signaling (Bamforth et al., 2001;
Bamforth et al., 2004), Hnf4α (Qu et al., 2007) and through other, as yet unknown, mechanisms.
The potential involvement of Cited2 in eye development was suggested by irregularly shaped
pupils typical of Cited2-deficient embryos at 13.5 days post-coitum (dpc) (Yin et al., 2002).
In this report, we show for the first time that Cited2 deficiency results in abnormal corneal-
lenticular stalk formation and vitreous hypercellularity consisting of aberrant vasculature in
the developing eye. We further demonstrate that Cited2 is an upstream positive regulator of
Pax6 expression in the lens; this regulation is the mechanism that underlies the corneal-
lenticular stalk formation resulting from Cited2 deficiency. In addition, our study also shows
that genetic interaction of Cited2 with HIF-1 signaling contributes to the appropriate formation
of the hyaloid vascular system (HVS) during development.
MATERIALS AND METHODS
Mouse lines and preparation of mouse embryos
Cited2+/− (Yin et al., 2002) and Cited2flox/flox (Preis et al., 2006) mouse lines were maintained
on the C57BL/6 background. Cited2flox/flox mice were mated with Le-Cre+ mice to generate
Cited2flox/flox;Le-Cre− and Cited2flox/flox;Le-Cre+ mice. Hif1aflox/flox (Cramer et al.,
2003);Le-Cre+ (Ashery-Padan et al., 2000) mice were mated with Cited2+/− mice to generate
embryos with the following genotypes: Cited2−/−;Hif1aflox/flox;Le-Cre+,
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Cited2−/−;Hif1aflox/flox;Le-Cre−, Cited2+/+;Hif1aflox/flox;Le-Cre+, Cited2+/+;Hif1aflox/flox;Le-
Cre−, Cited2+/−; Hif1aflox/flox;Le-Cre+, or Cited2+/−;Hif1aflox/flox;Le-Cre−. Primers for
genotyping were: HIF-1α-flox: antisense (a), 5′-
ATATGCTCTTATGAAGGGGCCTATGGAGGC-3′ and sense (s), 5′-
GATCTTTCCGAGGACCTGGATTCAATTCCC-3′; Le-Cre (a), 5′-
GCATTACCGGTCGATGCAACGAGTGATGAG-3′ and (s), 5′-
GAGTGAACGAACCTGGTCGAAATCAGTGCG-3′. PAX77 transgenic mice
overexpressing the human PAX6 gene (Schedl et al., 1996) were mated with Cited2+/− mice
to produce Cited2+/− mice carrying the PAX6 transgene. These compound mice were then
mated with Cited2+/− mice to obtain Cited2−/− embryos with and without the transgene at 14.5
dpc. PAX77 transgenic mice were genotyped as described previously (Kleinjan et al., 2006).
All animal husbandry and experiments were conducted in accordance with institutional
guidelines of Case Western Reserve University. Timed pregnancy of Cited2+/− females was
determined as 0.5 dpc if vaginal plug was found after overnight mating. Embryos were
harvested by a caesarean-driven method.
Histology
Embryos at 10.5, 11.5, 12.5, 13.5, 15.5 and 18.5 dpc were fixed in 10% formalin, dehydrated,
embedded in paraffin and processed with 7 μm transverse sectioning. Histology of the eyes
was examined by light microscopy after Hematoxylin and Eosin staining.
Immunohistochemistry and X-Gal staining for eye sections
For immunohistochemistry, embryonic tissues were fixed in 1-4% paraformaldehyde,
equilibrated in 12%, 15% and 20% sucrose, embedded in OCT and processed with 10 μm
cryosectioning. Immunostaining employed antibodies against Cited2 (Santa Cruz), E-cadherin
(cadherin 1) (BD Pharmingen) and α smooth muscle actin (α-SMA) (Sigma) and antibody
staining was visualized with Alexa594-conjugated anti-mouse secondary antibody (Molecular
Probes, Invitrogen). Phosphorylated histone H3 immunostaining was performed with anti-
phospho-H3 antibody (Cell Signaling) and the staining was visualized with Alexa488-
conjugated anti-rabbit secondary antibody (Molecular Probes, Invitrogen). Antibodies against
CD31 (Pecam1 – Mouse Genome Informatics) (BD Pharmingen) and VEGFR2 (Flk1; Kdr)
(BD Pharmingen) were visualized with 3,3′-diaminobenzidine (Sigma). Pax6 and AP2α
antibodies were obtained from Developmental Studies Hybridoma Bank at University of Iowa
and the staining was visualized by Alexa594-conjugated anti-mouse secondary antibody and
3,3′-diaminobenzidine, respectively. lacZ expression was detected by X-Gal (Roche) staining
and was performed on 1% paraformaldehyde-fixed eye sections according to standard methods.
TUNEL assay
Cryosections were collected from 10.5 dpc embryos after fixation in 4% paraformaldehyde
and processed for the TUNEL assay according to the manufacturer’s instruction (Chemicon).
Real-time RT-PCR
Total RNA was extracted using RNA Trizol (Invitrogen) and was reverse transcribed into
cDNA using the SuperScript First-Strand Synthesis System for RT-PCR Kit (Invitrogen). PCR
primers for detecting Pax6 expression in Cited2−/− and Cited2+/+ embryonic lens were:
antisense (a), 5′-CTACCAGCCAATCCCACAGC-3′ and sense (s), 5′-
TTCGGCCCAACATGGAAC-3′. Primers for detecting Pax6 expression in lenses collected
from Cited2−/−;PAX77 and Cited2−/− littermate control embryos were: (a), 5′-
ATGTTGCGGAGTGATTAGTGGG-3′ and (s), 5′-GCGAAGCCTGACCTCTGTCA-3′.
Vegf (Vegfa – Mouse Genome Informatics) and Hif1a mRNA expression was analyzed as
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described previously (Xu et al., 2007). The real-time PCR was performed in triplicate for each
sample on MyiQ (BioRad). Ct value was recorded to perform data analysis.
Luciferase assay
α-TN4-1, NMuMG and HEK293 cells were seeded in 12-well plates for transfection of 0.15
ng pRLSV40, 270 ng of LE9-P0, LE0-P0 or P0 firefly luciferase reporter, various amounts of
Cited2 expression plasmid, 75 ng of Pax6 expression plasmid, and control plasmid so that the
total amount of DNA was 1 μg/well. Fugene6 transfection reagent (Roche) was used for the
transfection. Firefly and Renilla luciferase activities were measured 24 hours after transfection
using Dual-Luciferase Assay Reagents (Promega) on a luminometer. Relative luciferase
activity was calculated by dividing firefly luciferase activity by Renilla luciferase activity.
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed in α-TN4-1 cells according to protocols
previously described (Yang and Cvekl, 2005; Yang et al., 2006) using antibodies against Cited2
and Pax6 (Santa Cruz). The immunoprecipitated DNAs were amplified by PCR and analyzed
by agarose gel electrophoresis. Primers for the ChIP assay spanning the Pax6 LE9 region and
the Pax6 P0 promoter region were: LE9 region (a), 5′-TGGGCAATGAGCGGAAAGAT-3′
and (s), 5′-TGTGTGCAAATGAAGGCTCTCC-3′; P0 region (a), 5′-
CGAGGGTGGGGTGTCAGGTG-3′ and (s), 5′-GCGGCTTTGAGAAGTGTGGG-3′.
Another pair of primers covering the region between LE9 and the P0 promoter was chosen as
a negative control (NC): (a), 5′-TCAAGGAACATCTGGCTCGC-3′ and (s), 5′-
GATGGGGCTCCACCAATCCA-3′.
RESULTS
Expression of Cited2 in the developing lens
Expression of Cited2 in the developing lens was examined by immunostaining of embryonic
eye sections. Cited2 expression was detected in the surface ectoderm at 9.5 dpc (Fig. 1A,E),
in the invaginating lens pit at 10.5 dpc (Fig. 1B,F), and in lens epithelial cells at later stages
such as 15.5 dpc (Fig. 1C,G). The expression of Cited2 was not detected in differentiated lens
fiber cells during lens development (Fig. 1C,G). The expression of Cited2 in the developing
lens suggests its potential involvement in lens morphogenesis. In addition to the lens, Cited2
was also expressed in the other developing ocular components, such as the cornea, the non-
pigmented layer of the ciliary epithelium and retina (Fig. 1C,G).
Abnormal corneal-lenticular stalk formation in Cited2−/− developing eyes
Gross morphological examination revealed several prominent abnormalities with full
penetrance in all the Cited2−/− eyes examined (Table 1). In the anterior part of Cited2−/− eyes,
abnormal corneal-lenticular stalk formation was consistently observed, which resembles
Peters’ anomaly, a congenital defect with persistent central adhesion between the lens and the
cornea (Yoon, 2001;Smith and Velzeboer, 1975;Myles et al., 1992;Kenyon, 1975). In contrast
to wild-type littermate controls (Fig. 2A,C,E), Cited2−/− lens vesicles failed to separate from
the surface ectoderm at 11.5 dpc (Fig. 2B), resulting in a persistent corneal-lenticular stalk as
shown by representative pictures from 15.5 dpc (Fig. 2D) and 18.5 dpc (Fig. 2F). The corneal-
lenticular stalk was further examined by immunostaining of E-cadherin. Abnormal corneal-
lenticular stalk in Cited2−/− eyes (Fig. 2H), which was absent from the wild-type control (Fig.
2G), was positively stained for E-cadherin, validating the epithelial characteristics of the
corneal-lenticular stalk. In addition, a distinctive endothelial layer on the posterior side of the
cornea developed in wild-type eyes by 15.5 dpc (see Fig. S1A in the supplementary material),
whereas it was absent in Cited2−/− eyes (see Fig. S1B in the supplementary material).
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Cited2−/− developing lenses were also smaller than in the wild type. Decreased lens size was
first noted as early as 10.5 dpc in Cited2−/− embryos as smaller invaginating lens placodes (see
Fig. S2B in the supplementary material) than in wild-type littermate controls (see Fig. S2A in
the supplementary material). Smaller lens vesicles were thus formed in the developing
Cited2−/− eyes at 11.5 dpc as shown above (Fig. 2B), and the Cited2−/− lenses remained small
throughout the subsequent stages until 18.5 dpc (see Fig. S2D in the supplementary material),
as compared with wild-type littermate controls (see Fig. S2C in the supplementary material).
Retinal folding was also invariably detected in Cited2−/− eyes at 18.5 dpc (see Fig. S2D in the
supplementary material), which might, in part, result from abnormal lens formation (Chow and
Lang, 2001).
Proliferation and cell death rate in early Cited2−/−developing lens
To further explore the mechanisms responsible for small lens size in Cited2−/− eyes,
proliferation of the lens cells was examined by the expression of a mitosis marker,
phosphorylated histone H3, in the developing lens at 10.5 dpc. As shown in Fig. 3, no
significant difference in mitosis was revealed when Cited2−/− lens (n=5) (Fig. 3B) was
compared with Cited2+/+ littermate controls (n=3) (Fig. 3A) [14.3±1% in Cited2+/+ versus 12.5
±1.6% in Cited2−/− lens, P>0.05 (Fig. 3C)]. Cell death in the developing lens at 10.5 dpc was
also examined in parallel by the TUNEL assay. Compared with the Cited2+/+ littermate controls
(n=3) (Fig. 3D), increased cell death was detected in the Cited2−/− lens (n=5) (Fig. 3E) [13.5
±1.8% in Cited2+/+ versus 25.1±5.4% in the Cited2−/− lens, P<0.01 (Fig. 3F)]. Collectively,
Cited2 deficiency may result in increased cell death during early lens development, which in
turn may contribute to the smaller lens size at subsequent developmental stages.
Aberrant vitreous hypercellularity consisting of aberrant vascularization in Cited2−/−
developing eyes
In the posterior part of Cited2−/− eyes, hypercellularity of the hyaloid vasculature was observed.
Fig. 4 shows representative pictures of Cited2−/− eyes from 15.5 (Fig. 4B) and 18.5 dpc (Fig.
4D) and wild-type littermate controls from corresponding stages (Fig. 4A,C). Further
immunohistochemical examination for vasculature was performed with antibodies against
CD31, a molecular marker for vascular endothelial cells, and vascular endothelial growth factor
(VEGF) receptor 2 (VEGFR2), which is expressed by angioblast cells and vascular endothelial
cells (Ash and Overbeek, 2000). In wild-type littermate controls at 15.5 dpc, CD31 (Fig. 4E)
and VEGFR2 expression (Fig. 4G) was detected in pupillary membrane vessels, tunica
vasculosa lentis and vasculature overlying the developing retina. However, Cited2−/− eyes were
predominantly featured by excessive and disorganized vasculature in the developing vitreous
that was positive for expression CD31 (Fig. 4F) and VEGFR2 (Fig. 4H).
Cited2 is required for the regression of the hyaloid vascular system through modulating
HIF-1 signaling during eye development
Angiogenic factor VEGF is expressed in different components of the developing eye, including
the lens, the cornea and the retina, suggesting that VEGF might be one of the growth factors
that initiate intraocular angiogenesis (Flamme et al., 1995). Overproduction of VEGF in the
lens results in excessive accumulation of angioblasts and endothelial cells, indicating that the
expression level of VEGF in the lens is critical for the maturation of the HVS (Ash and
Overbeek, 2000; Mitchell et al., 2006; Rutland et al., 2007). VEGF is a direct target of HIF-1
(Liu et al., 1995; Shweiki et al., 1992) and, importantly, Cited2 has been shown to be a negative
regulator for HIF-1 signaling through its competitive binding to the CH1 domain of CBP/p300
with higher affinity than does HIF-1α (Bhattacharya et al., 1999). In Cited2-deficient mouse
heart, HIF-1 signaling is deregulated, as evidenced by increased expression of HIF-1-inducible
genes, including Vegf (Yin et al., 2002). HIF-1α haploinsufficiency decreases VEGF
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expression and rescues the heart defects in Cited2-deficient embryos (Xu et al., 2007),
indicating that upregulated HIF-1 signaling is in part responsible for defective cardiac
morphogenesis resulting from Cited2 deficiency. Altered expression of VEGF as a result of
upregulated HIF-1 signaling is of significance considering the role of VEGF in the hyaloid
vascularization. Interestingly, a 4.5-fold increase in the Vegf mRNA level was detected in
Cited2−/− lens compared with the wild-type littermate control (Fig. 4I), suggesting that
upregulated HIF-1 signaling as a result of Cited2 deficiency could be responsible for the
elevated VEGF expression and hyaloid hypercellularity and aberrant vascularization in
Cited2−/− eyes. We tested this hypothesis by introducing Le-Cre (Ashery-Padan et al., 2000)
mediated lens-specific deletion of Hif1a in Cited2-deficient eyes. Cited2−/−;Hif1aflox/flox;Le-
Cre− eyes reproducibly displayed the persistence of lens stalk and hyaloid hypercellularity
with aberrant vasculature at 15.5 (Fig. 5A) and 17.5 dpc (Fig. 5C) (n=3), which contrasted with
the normal littermate control at 15.5 dpc (see Fig. S3A,B in the supplementary material) and
17.5 dpc (see Fig. S3C,D in the supplementary material) (n=2). Furthermore, compared with
Cited2−/−;Hif1aflox/flox;Le-Cre− eyes, hyaloid hypercellularity with aberrant vasculature was
not detected in Cited2−/−;Hif1aflox/flox;Le-Cre+ eyes from the same litters at the corresponding
stages; however, the corneal-lenticular stalk was still present in these eyes (n=3) (Fig. 5B,D).
The efficiency of Le-Cre transgene-mediated deletion of Hif1a in Cited2−/− eyes was also
assessed by analyzing Hif1a mRNA expression in the lens at 14.5 dpc. The result showed a 5-
fold reduction of Hif1a mRNA expression in Cited2−/−;Hif1aflox/flox;Le-Cre+ lens (n=3)
compared with that in Cited2−/−;Hif1aflox/flox;Le-Cre− littermate controls (n=3) (Fig. 5E).
Furthermore, there was a 3-fold reduction in the Vegf mRNA level in
Cited2−/−;Hif1aflox/flox;Le-Cre+ lens (n=3) compared with Cited2−/−;Hif1aflox/flox;Le-Cre−
littermate controls (n=4) (Fig. 5F). Thus, our results support the hypothesis that upregulated
HIF-1 signaling as a result of Cited2 deficiency is indeed responsible for the aberrant vitreous
hypercellularity and disorganized hyaloid vasculature, as deletion of Hif1a in the lens can
specifically rescue this phenotype in Cited2-deficient eyes.
Cited2 positively regulates Pax6 expression in the lens
Transcription factor Pax6 is a highly conserved master regulator for eye development (Grindley
et al., 1995; Chow and Lang, 2001) and Pax6 gene dosage exerts a critical influence on lens
morphogenesis. Haploinsufficiency of Pax6 results in abnormal lens morphogenesis
highlighted by corneal-lenticular stalk formation (Dimanlig et al., 2001; Davis-Silberman et
al., 2005), which shares striking similarities with the corneal-lenticular stalk phenotype
observed in Cited2−/− eyes. Moreover, the expression of Cited2 in lens epithelial cells overlaps
with that of Pax6 in the developing eye (Grindley et al., 1995; Walther and Gruss, 1991). We
thus hypothesized that Cited2 might affect the level of Pax6 expression in developing lens and
that decreased Pax6 expression in Cited2-deficient eyes might lead to corneal-lenticular stalk
formation. To explore this possibility, immunostaining of Pax6 was performed. An appreciable
level of Pax6 expression in Cited2−/− lens epithelial cells was detected at 13.5 dpc (Fig. 6B)
as compared with the wild-type littermate control (Fig. 6A). Since a quantitative comparison
of Pax6 expression levels was hard to achieve by immunostaining, we compared mRNA
expression of Pax6 in wild-type and Cited2-deficient lens at 14.5 dpc by real-time PCR. We
observed a 2.5-fold reduction in Pax6 mRNA expression in Cited2−/− lens (n=4) as compared
with wild-type littermate controls (n=4) (Fig. 6C).
Pax6 expression in the lens is regulated through a series of cis-regulatory elements in addition
to its promoter for correct spatiotemporal and quantitative expression (Xu et al., 1999;
Kammandel et al., 1999; Kleinjan et al., 2006). Transgenic studies in conjunction with gene-
targeting strategy and in vitro studies have established that the head surface ectoderm enhancer
is one of the major regulators for Pax6 expression in the lens (Kammandel et al., 1999).
Disruption of the ectoderm enhancer causes lens defects including small lens and fusion of the
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lens to the surface ectoderm (Dimanlig et al., 2001). In vitro studies have identified a Pax6-
responsive element in the ectoderm enhancer and established a model in which Pax6 protein
regulates its own expression through a direct interaction of Pax6 with the surface ectoderm
enhancer (Aota et al., 2003). To further examine the potential involvement of Cited2 in
regulating Pax6 expression, reporter constructs containing the Pax6 promoter (P0) and two
enhancer fragments, LE9 (LE9-P0) and LE0 (LE0-P0) (Aota et al., 2003), responsible for
autoregulated expression of Pax6, were tested in a lens epithelial cell line, α-TN4-1, which
expresses a high endogenous level of Pax6 (Yang and Cvekl, 2005), and in a normal mouse
mammary gland epithelial cell line, NMuMG, which does not express Pax6. In α-TN4-1 cells,
Cited2 overexpression significantly increased LE9-P0 reporter activity (Fig. 6D,E) in a dose-
dependent manner (data not shown). In addition, LE0-P0 and P0 reporter activity was enhanced
when Cited2 was overexpressed (Fig. 6D). However, in NMuMG cells in which Pax6 is absent,
Cited2 expression had no effect on the LE9-P0 reporter activity. When Cited2 was co-expressed
with Pax6 in NMuMG cells, the reporter activity was significantly increased as compared with
Pax6 alone (Fig. 6E). Similar data were obtained in human embryonic kidney (HEK293) cells
(Fig. 6E). Chromatin immunoprecipitation (ChIP) was then carried out to test whether Cited2
is physically present on the Pax6 ectoderm enhancer and the P0 promoter region using
chromatin prepared from α-TN4-1 cells. The results showed that Cited2 is present on the
genomic region covering the LE9 sequence and the Pax6 P0 promoter (Fig. 6Fa,b), but absent
in other regions upstream of the Pax6 P0 promoter (Fig. 6Fc). This is consistent with the
transfection results (Fig. 6D) and the previous finding that Pax6 binds the LE9 enhancer and
the P0 promoter of the Pax6 gene (Aota et al., 2003). These data strongly suggest that Cited2
is a potential positive regulator for Pax6 expression in the lens.
To definitively demonstrate that Cited2 is a positive regulator of Pax6 in vivo, we generated
compound embryos by crossing the PAX6 transgenic mouse line (Schedl et al., 1996) onto a
Cited2 knockout background to test whether the Cited2-deficient lens phenotype could be
rescued by increasing Pax6 gene dosage. As shown in Fig. 6E, Cited2−/−;Pax6− mouse embryos
reproducibly displayed corneal-lenticular stalk formation (n=2) (Fig. 6G), whereas the
abnormal corneal-lenticular stalk was never detected in any of the Cited2−/−;Pax6+ embryos
analyzed (n=3) (Fig. 6H). Quantitative analysis revealed a 2.3-fold increase of Pax6 mRNA
expression in Cited2−/−;Pax6+; mouse lens (n=3) as compared with that from
Cited2−/−;Pax6− littermate controls (n=3) (data not shown). Our data thus indicate that
increased Pax6 expression in Cited2-deficient embryos is able to correct abnormal corneal-
lenticular stalk formation. These data provide direct evidence that decreased Pax6 expression
is indeed responsible for the corneal-lenticular stalk formation in Cited2-deficient embryos.
Therefore, Cited2 is essential for lens morphogenesis by functioning upstream of, and/or
together with, Pax6, as the latter increases its own expression. Taken together, our in vitro and
in vivo data demonstrate that Cited2 is a novel regulator for Pax6 expression in the lens.
Cited2 is required for lens morphogenesis and proper regression of HVS
Since targeted deletion of Cited2 is embryonic lethal, to further address the role of Cited2 in
lens morphogenesis and HVS formation and regression in adult mice, lens-specific deletion of
Cited2 was generated by crossing Cited2flox/flox mice with Le-Cre transgenic mice. It is worth
noting that the construct strategy allows lacZ to be expressed under the control of the Cited2
promoter when the floxed Cited2 allele is recombined (Preis et al., 2006). Therefore, we could
assess the Le-Cre transgene-mediated recombination of floxed Cited2 alleles by X-Gal
staining. As shown in Fig. 7, lacZ expression was readily detected in Cited2flox/flox;Le-Cre+
eyes during early lens development, including lens placode at 9.5 dpc (Fig. 7A), invaginating
lens pit at 10.5 dpc (Fig. 7B) and lens vesicle at 11.5 dpc (Fig. 7C), whereas no lacZ staining
was detected in Cited2flox/flox;Le-Cre−control eyes (Fig. 7D). Additionally, failed separation
of the lens from the surface ectoderm at 11.5 dpc was recapitulated in the Cited2flox/flox;Le-
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Cre+ eye (Fig. 7C), as was shown in Cited2−/−eyes at the same developmental stage (Fig. 2B).
These results indicate that (1) the Le-Cre transgene mediates successful deletion of Cited2 in
the developing lens and (2) the Le-Cre transgene is active in developing lens starting from the
lens placode stage, which is consistent with what was reported previously (Ashery-Padan et
al., 2000).
Moreover, morphological examination revealed that compared with the Cited2flox/flox;Le-
Cre− littermate control at 6 weeks of age (Fig. 7E), the Cited2flox/flox;Le-Cre+ eye was smaller
and displayed failed formation of the anterior chamber (Fig. 7F). This was further supported
by histological analysis, which showed failed separation of the lens from the cornea and
defective anterior chamber formation (Fig. 7H) as compared with the normal histological
feature exhibited by the Cited2flox/flox;Le-Cre−littermate control (Fig. 7G). In addition,
abnormal retrolental tissue was invariably noted in Cited2flox/flox;Le-Cre+ eyes (Fig. 7J)
compared with the Cited2flox/flox;Le-Cre− littermate control (Fig. 7I). Higher magnification
revealed that the retrolental mass consists of melanocytes and blood vessels (Fig. 7K), and the
latter was confirmed by immunostaining for α smooth muscle actin, which labels the pericytes
that stabilize the vessels (Fig. 7L). These results indicate that Cited2 is required for lens
morphogenesis and that Cited2 deficiency is associated with abnormal HVS regression in the
eye.
DISCUSSION
The current study is the first evaluation of the role of Cited2 in eye morphogenesis. Our results
show that Cited2 is expressed in the developing eye and that deletion of Cited2 disturbs normal
eye development, causing fusion of the lens to the cornea and hyaloid hypervascularity. Genetic
interaction of Cited2 with HIF-1 signaling is specifically involved in the process of HVS
formation. In addition, Cited2 functions upstream of, and/or together with, Pax6, a key
transcription factor in lens morphogenesis.
Function of Cited2 in regulating the fetal vasculature
Fetal hyaloid vasculature is required to provide nutrients to various compartments of the
developing eye. However, the hyaloid vasculature is a transient blood supply system in that a
gradual loss followed by a nearly complete regression is achieved during postnatal ocular
development in mammals (Ito and Yoshioka, 1999). Abnormalities in the process of intraocular
vascularization during embryogenesis are linked to several disorders, including Persistent fetal
vasculature (PFV) with vision impairment (Pollard, 1997; Haddad et al., 1978; Goldberg,
1997). The mechanisms responsible for the fetal hyaloid vasculogenesis and subsequent
regression have not been clearly defined.
Our current study provides evidence that Cited2-HIF-1 genetic interaction plays an important
role in this process. HIF-1 signaling is the major machinery that responds to low oxygen level
in various tissue types. Under hypoxic condition, HIF-1α, the subunit of HIF-1 whose
expression is controlled by oxygen levels, accumulates, binds with its heterodimeric partner,
HIF-1β, translocates to the nucleus, binds to hypoxia-response elements and recruits p300 via
the CH1 domain, thus activating the transcription of its target genes, including Vegf (Pugh and
Ratcliffe, 2003; Arany et al., 1996). Cited2 is a hypoxia-inducible gene that modulates HIF-1
signaling by binding p300 with higher affinity than does HIF-1α. This competitive binding
reduces hypoxia-activated transcription (Freedman et al., 2003; Bhattacharya et al., 1999).
Therefore, as a negative regulator for HIF-1 signaling, Cited2 plays an important role in
controlling the HIF-1α-mediated hypoxia response. Our previous studies have shown that in
Cited2−/− mouse hearts, HIF-1 signaling is upregulated, as measured by increased expression
of HIF-1 target genes, including Vegf (Yin et al., 2002). Furthermore, HIF-1α
haploinsufficiency partially rescues heart morphogenic phenotypes, providing evidence that
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Cited2 deficiency causes deregulated HIF-1 signaling under hypoxic conditions and that the
latter is partially responsible for the heart malformations in Cited2−/−embryos (Xu et al.,
2007).
The lens exists in a hypoxic environment (Bassnett and McNulty, 2003; Shui et al., 2003; Shui
et al., 2006). The role of VEGF in intraocular vascularization has been studied extensively.
Preliminary reports suggest that deletion of VEGF in the lens prevents the formation of the
capillary network on the posterior of the lens without disturbing lens formation or the
establishment of hyaloid vasculature (Beebe, 2008). By contrast, increased expression of
VEGF in the lens invariably leads to the production of excess, aberrant hyaloid vascularization
(Ash and Overbeek, 2000; Mitchell et al., 2006; Rutland et al., 2007). Based on these findings
and the data presented in this work, increased VEGF levels resulting from deregulated Cited2-
HIF-1 could be considered as one of the factors involved in aberrant hyaloid vascularization
in Cited2−/− eyes. However, our results do not exclude the possibility that other mechanisms
might also be involved. Specific deletion of Vegf in Cited2−/− lens will help to clarify the role
of Cited2-HIF-1 interaction in the control of lenticular VEGF production during eye
development and the participation of other growth factors in the process. Since mutants that
form smaller lenses often have more mesenchyme in the vitreous (Beebe et al., 2004), it is
possible that the smaller lens resulting from deletion of Cited2 might allow more mesenchymal
cells to migrate into the developing vitreous, directly or indirectly promoting the formation of
an increased vascular supply. Alternatively, lower levels of anti-angiogenic factors could be
produced by the mutant lens, which might perturb the necessary balance between angiogenic
and anti-angiogenic factors during HVS development.
Since HIF-1 signaling is also involved in regulating cell death and proliferation (Carmeliet et
al., 1998), it might control the size of the lens through these mechanisms and, in turn, affect
hyaloid vascularization. Our preliminary data showed that Cited2-deficient lens appeared to
have increased levels of apoptotic cells at 10.5 dpc, which was only partially corrected by
deleting Hif1a in Cited2-deficient eyes (data not shown). Proliferation assays did not reveal
any obvious changes in Cited2-deficient embryos compared with their wild-type littermate
controls. This is consistent with the conclusion that HIF-1 is not the decisive factor controlling
lens growth in younger animals (Beebe, 2008). Further analysis will be required to define the
relative contributions of lens size, VEGF expression, hyaloid vascularization and migration of
mesenchymal cells to the formation of the HVS. Conditional deletion of both Cited2 and
Hif1a might further clarify whether Cited2-HIF-1α interaction contributes to the regression of
the HVS postnatally.
Function of Cited2 in lens morphogenesis
Our data have shown that the formation of a corneal-lenticular stalk in Cited2−/− eyes is
mediated by mechanisms independent of HIF-1, as lens-specific deletion of Hif1a did not
rescue this defect. Pax6 is a key regulator for various eye developmental events including lens
morphogenesis (Hill et al., 1991; Hanson et al., 1994; Kaufman et al., 1995; Quiring et al.,
1994). Pax6 gene dosage is critical for lens morphogenesis, which is supported by independent
studies from Sey heterozygous mice (van Raamsdonk and Tilghman, 2000; Hill et al., 1991),
Pax6 head surface ectoderm enhancer null mice (Dimanlig et al., 2001) and Pax6 single allele
knockout mice (Davis-Silberman et al., 2005). For example, Pax6 single allele deletion in the
lens results in a 34% reduction in the Pax6 level in Pax6flox/+;Le-Cre+ mouse lens epithelium,
which is sufficient to cause corneal-lenticular stalk formation in the eye (Davis-Silberman et
al., 2005). In human, heterozygous PAX6 mutations are associated with Peters’ anomaly
(Hanson et al., 1994; Smith and Velzeboer, 1975; Myles et al., 1992; Kenyon, 1975), in which
the patients are characterized by fusion of the lens to the cornea. Owing to its gene dosage
effect on lens morphogenesis, transcriptional control of Pax6 gene expression has been the
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subject of a number of studies, which have identified a series of cis-regulatory elements
upstream of Pax6, within the introns of Pax6, downstream of Pax6 or within the introns of an
adjacent gene (Williams et al., 1998; Xu et al., 1999; Kammandel et al., 1999; Kleinjan et al.,
2001; Kleinjan et al., 2002; Kleinjan et al., 2006). Cited2 deficiency resulted in corneal-
lenticular stalk formation and decreased Pax6 expression, suggesting that Cited2 might control
Pax6 expression. Our in vitro data also suggested that Cited2 could be a positive regulator for
Pax6 autoregulation. In vivo data from Cited2−/−;Pax6+ mouse embryonic eyes showed that
increasing Pax6 gene dosage in Cited2−/− eyes corrected the corneal-lenticular stalk phenotype,
providing direct genetic evidence that Cited2 is required for normal levels of Pax6 expression
in the lens. Although we found that Cited2 regulated Pax6 expression through its action on
regions within the upstream head surface ectoderm enhancer and the P0 promoter, we cannot
exclude the possible involvement of downstream regulatory elements (Kleinjan et al., 2006)
in Cited2-mediated expression of Pax6. Further studies are necessary to determine how Cited2
interacts with these cis elements to control Pax6 expression. Additionally, although a direct
physical interaction between Pax6 and Cited2 was not detected by co-immunoprecipitation
after overexpressing Pax6 and Cited2 in HEK293 cells (data not shown), it is possible that
Cited2, Pax6 and other proteins, such as Sox2 (Aota et al., 2003) and Oct1 (Pou2f1 – Mouse
Genome Informatics) (Donner et al., 2007), are present in a multi-protein complex.
Biochemical characterization of this multi-protein complex will be necessary to provide a
molecular basis for Cited2 involvement in the autoregulation of Pax6 expression. It is also
worth noting that although Cited2 activates Pax6 upstream regulatory elements in vitro (Fig.
6D), Cited2 might not be the only molecule controlling Pax6 expression in the developing lens.
This is in part supported by the observation that Cited2 homozygous deletion only results in a
2.5-fold reduction of the Pax6 mRNA level in the developing lens (Fig. 6C). In addition, the
Le-Cre transgene driven by the Pax6 upstream ectoderm enhancer and the P0 promoter in the
Cited2-null background efficiently deletes floxed Hif1a (Fig. 5), suggesting that other factors
might also contribute to the transcriptional activity of the Pax6 upstream ectoderm enhancer
and P0 promoter.
Although we have provided experimental evidence that Cited2 plays important roles in lens
morphogenesis in part through regulating Pax6 expression in the developing lens, other
mechanisms, involving, for example, AP2α cannot be ruled out at the present time. Cited2 and
AP2α physically interact to impact cardiac morphogenesis, left-right patterning and neural tube
formation (Bamforth et al., 2001; Bamforth et al., 2004). Ap2a-null mice display eye
developmental defects, such as corneal-lenticular adhesion, demonstrating that AP2α is
required for lens development (West-Mays et al., 1999). We detected appreciable level of
AP2α in Cited2−/− lens epithelial cells (see Fig. S4B in the supplementary material) as
compared with wild-type littermate controls (see Fig. S4A in the supplementary material).
Cited2 could function as a co-activator of AP2α to regulate the expression of its as-yet-
unidentified target genes, which in turn would contribute to the lens phenotypes observed in
Cited2−/−eyes.
As a transcriptional modulator, Cited2 has been shown to be involved in the development of
several organs and tissues. However, the role of Cited2 in eye development has not been
explored previously. The current study has uncovered a novel function of Cited2 in lens
morphogenesis and hyaloid vascular development, and offers mechanistic views of how Cited2
functions in these processes. This information might shed new light on the etiology of, and
potential therapeutic strategies for, eye disorders such as Peters’ anomaly and PFV.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Cited2 is expressed in the developing mouse lens
Immunostaining for Cited2 on eye sections from various developmental stages. Cited2
expression (red) was detected in the surface ectoderm at 9.5 dpc (A), invaginating lens placode
at 10.5 dpc (B), and in lens epithelial cells at 15.5 dpc (C), but not in the negative control
(D). Cited2 immunostaining (red) (E-G) and negative control (H) from corresponding stages
were merged with DAPI nuclei staining (blue).
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Fig. 2. Formation of the lens stalk in Cited2−/− eyes
(A-F) Histological examination was performed after Hematoxylin and Eosin (H&E) staining
of serial paraffin sections of mouse embryo heads. Compared with wild-type littermate controls
at corresponding stages (A,C,E), fusion of the lens to the surface ectoderm was detected at 11.5
dpc (arrow in B) and the resultant lens stalk persisted throughout development as shown in
representative pictures from 15.5 (arrow in D) and 18.5 dpc (arrow in F) in Cited2−/− eyes.
(G,H) E-cadherin immunostaining was performed on sections from 13.5 dpc. In contrast to the
expression in corneal epithelium and lens epithelial cells in the wild-type littermate control
(G), positive E-cadherin staining for lens stalk was revealed in Cited2−/− eyes (arrow in H).
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Fig. 3. Proliferation and cell death in Cited2−/− lens
(A-C) Proliferation of the developing mouse lens at 10.5 dpc was examined by phosphorylated
histone H3 immunostaining (green) and counterstained with DAPI (blue). No significant
difference in proliferation was detected between Cited2+/+ littermate controls (A) (n=3) and
Cited2−/− lens (B) (n=5); the data are summarized in C (P>0.05). (D-F) Cell death of the
developing lens at 10.5 dpc was examined by the TUNEL assay. For counting cell number,
sections were counterstained with DAPI to reveal nuclei (data not shown). Compared with
Cited2+/+ littermate controls (D) (n=3), increased cell death was observed in Cited2−/− lens
(E) (n=5); the data are summarized in F (P<0.01).
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Fig. 4. Hyaloid hypercellularity and aberrant vasculature in Cited2−/− eyes
(A-D) Histological examination was performed after H&E staining of serial paraffin sections
of mouse embryo heads. The analysis revealed hyaloid hypercellularity and aberrant
vasculature in Cited2−/− eyes at 15.5 (arrow in B) and 18.5 (arrow in D) dpc, in comparison to
normal intraocular vasculature in wild-type littermate controls at 15.5 (A) and 18.5 (C) dpc.
(E-H) The abnormal vasculature was further confirmed by immunostaining Cited2−/− eye
sections at 15.5 dpc for endothelial cells by CD31 (arrow in F) and endothelial and angioblast
cells by VEGFR2 (arrow in H), as compared with normal expression patterns for CD31 (E)
and VEGFR2 (G) in wild-type controls. (I) Vegf mRNA expression was increased in
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Cited2−/− lens (n=4) compared with the wild-type littermate control (n=4), as quantified by
real-time PCR analysis.
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Fig. 5. Deletion of Hif1a in the lens specifically eliminates the hyaloid hypercellularity and aberrant
vasculature of Cited2−/−eyes
(A-D) H&E-stained serial paraffin sections of mouse embryo heads at 15.5 and 17.5 dpc
revealed that at both stages, Cited2−/−;Hif1aflox/flox;Le-Cre− eyes displayed lens stalk
formation (arrowhead in A,C) and hyaloid hypercellularity with aberrant vasculature (arrow
in A,C) (n=3). In Cited2−/−;Hif1aflox/flox;Le-Cre+ eyes (n=3), only the lens stalk (arrowhead
in B,D), but not the hyaloid hypercellularity, was detected. Data shown are representative of
three independent litters examined. (E) Le-Cre transgene-mediated deletion of Hif1a was
assessed by real-time PCR analysis of Hif1a mRNA expression at 14.5 dpc, which revealed a
5-fold decrease in the Hif1a mRNA level in Cited2−/−;Hif1aflox/flox;Le-Cre+ lens (n=3)
compared with the level detected in Cited2−/−;Hif1aflox/flox;Le-Cre− lens (n=3). (F) As a
consequence, Vegf mRNA expression decreased about 3-fold in Cited2−/−;Hif1aflox/flox;Le-
Cre+ lens (n=3) compared with the level detected in Cited2−/−;Hif1aflox/flox;Le-Cre− lens
(n=3).
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Fig. 6. Cited2 is a positive regulator for Pax6 expression
(A,B) Expression of Pax6 in Cited2−/− lens epithelial cells. Immunostaining revealed an
appreciable level of Pax6 expression in Cited2−/− lens epithelial cells at 13.5 dpc (B) compared
with that of wild-type littermate controls (A). (C) Pax6 mRNA expression in developing lens
at 14.5 dpc was analyzed by real-time PCR, which revealed a 2.5-fold reduction of Pax6
expression in Cited2−/− lens (n=4) as compared with wild-type littermate controls (n=4).
(D,E) Effect of Cited2 on Pax6 autoregulation. Transcriptional activation of reporters
containing Pax6 enhancer and promoter fragments, LE9-P0, LE0-P0 and P0, in Cited2- or
Pax6-overexpressing cells was measured by reporter assays. α-TN4-1 mouse lens epithelial
cells were transfected with a reporter plasmid containing the indicated fragment (270 ng) with
different combinations of Cited2 (225 ng) and Pax6 (75 ng) expression plasmids. Cited2
overexpression in Pax6-expressing α-TN4-1 cells significantly increased the activity of LE9-
P0, LE0-P0 and P0 reporters (D). This effect was Pax6-dependent because Cited2
overexpression had no effect on LE9-P0 reporter activity in NMuMG and HEK293 cells, which
do not express Pax6, but co-expression of Pax6 and Cited2 significantly increased the reporter
activity (E). (F) Cited2 is present on the Pax6 promoter. ChIP assays were performed using
2×106 α-TN4-1 cells and antibodies against Cited2 and Pax6. The precipitated DNA was
analyzed by PCR with primers covering the LE9 ectoderm enhancer and the P0 promoter
region. Normal mouse IgG and PCR amplifying the sequence between LE9 and P0 were also
included as negative controls. Input was 10% of the chromatin for immunoprecipitation.
Representative pictures show occupancy of Cited2 on LE9 (a) and P0 region (b) as compared
with the negative control (NC) (c). (G,H) Histological examination was performed after H&E
staining of paraffin-embedded eye serial sections collected from Cited2−/−;PAX77− and
Cited2−/−;PAX77+ littermates at 14.5 dpc. Abnormal lens stalk formation was consistently
detected in Cited2−/−;PAX77− embryonic eyes (n=2) (arrowhead in G). However, no lens stalk
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was detected in any of the serial sections collected from Cited2−/−;PAX77+ mouse embryos
(n=3) (H).
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Fig. 7. Le-Cre-mediated deletion of Cited2
(A-D) Le-Cre transgene-mediated recombination of floxed Cited2 alleles was revealed by
lacZ staining in Cited2flox/flox;Le-Cre+ developing mouse lens at 9.5 (A), 10.5 (B) and 11.5
(C) dpc, which is in contrast to the negative lacZ staining pattern in Cited2flox/flox;Le-Cre−
control eyes (D). (E,F) Macroscopic examination revealed smaller eyes and failure to form the
anterior chamber in Cited2flox/flox;Le-Cre+ embryos (F) as compared with those from
Cited2flox/flox;Le-Cre− embryos (E) at 6 weeks of age. (G-L) H&E staining of cross-sections
revealed failed separation of the lens from the cornea in Cited2flox/flox;Le-Cre+ eyes (arrow in
H) as compared with the normal histology in Cited2flox/flox;Le-Cre− eyes (G) at 6 weeks of
age. In addition, abnormal retrolenticular tissue (boxed) was also detected in
Cited2flox/flox;Le-Cre+ eyes (J) as compared with Cited2flox/flox;Le-Cre− controls (I). Higher
magnification of boxed retrolenticular tissue from J shows melanocytes and aberrant blood
vessels (K). Immunostaining for α-SMA (red) and counterstaining with DAPI (blue)
demonstrates α-SMA-positive pericytes surrounding the blood vessels in Cited2flox/flox;Le-
Cre+ eyes (L). R, retina.
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Table 1
Summary of ocular phenotypes in Cited2-deficient embryos
Stage dpc* Irregular pupil† Small lens pit/lens† Lens stalk† Aberrant vasculature†
10.5 (4) N/A 4 N/A N/A
11.5 (4) N/A 4 4 4
12.5 (10) N/A 10 10 10
13.5 (16) 16 16 16 16
14.5 (10) 10 10 10 10
15.5 (10) 10 10 10 10
18.5 (12) 12 12 12 12
*
The number of embryos analyzed is indicated in parentheses.
†
The number of embryos identified with the indicated defect.
N/A, not applicable.
Development. Author manuscript; available in PMC 2009 September 1.
